GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal
10 Jan 2024 //
REUTERS
Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments
12 Dec 2023 //
BUSINESSWIRE
Aiolos Bio Launches with $245 Million Series A Investment
24 Oct 2023 //
BUSINESSWIRE
Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets
24 Oct 2023 //
ENDPTS
Aiolos Bio launches with $245M to advance severe asthma med
24 Oct 2023 //
FIERCE BIOTECH